On Feb. 1, UnitedHealthcare enacted a new policy designating Avsola and Inflectra as the preferred infliximab products for UHC commercial plans. ACR leaders have urged UHC to allow existing patients to continue on their current medication.
Rosalind Ramsey-Goldman, MD, DrPH, Becomes Next Chair of the Collaborative Initiatives Special Committee
At the helm of the Collaborative Initiatives Special Committee (COIN), Rosalind Ramsey-Goldman, MD, DrPH, will oversee projects to tackle disparities within rheumatologic care, improve the inclusiveness of ACR initiatives, advance professional development in rheumatology topics and more.
Successful Resolutions, Policy Updates at AMA House of Delegates 2020 Interim Meeting
At the virtual interim meeting Nov. 13–17, the ACR delegation led a successful bid to update American Medical Association policies on home infusion and copay accumulators and supported efforts against the Most Favored Nation drug pricing model.
Kristine Kuhn, MD, PhD, Takes Reins of ACR’s Committee on Research
Dr. Kuhn hopes to expand funding for rheumatology research and enhance the ACR’s basic and clinical research pre-conference offerings during her term as chair.
ACR Advocacy: 2020 Year in Review
As a new year begins, Government Affairs Committee Chair Blair Solow, MD, takes stock of ACR advocacy wins in 2020 and issues to watch in 2021, including workforce issues, continued telemedicine access, prior authorization relief, Medicare reimbursement and drug pricing.
RHIT Chair William F. Harvey, MD, MSc, Promotes the Use of Health Data to Improve Practice and Care
As the new chair of the Registries & Health Information Technology Committee, William F. Harvey, MD, MSc, hopes to expand representation of patient diversity in the RISE registry and increase the use of registry data for research.
Marcus Snow, MD, FACR, Assumes Chair of the Committee on Rheumatologic Care
Marcus Snow, MD, FACR, had his first exposure to rheumatology in a rotation during his residency at the University of Nebraska Medical Center, Omaha. James O’Dell, MD, Theodore Mikuls, MD, Jay Moore, MD, Lynn Klassen, MD, and other physicians showed how rheumatology could be the perfect mix of a narrow clinical focus with interesting patient…
Landmark Supreme Court Decision Supports States’ Rights to Regulate Pharmacy Benefit Managers
On Dec. 10, the Supreme Court of the United States of America (SCOTUS) issued a landmark decision in Rutledge, Attorney General of Arkansas, v. Pharmaceutical Care Management Association. In an 8–0 decision, the justices agreed that states have the right to impose regulations on pharmacy benefit managers (PBMs), companies that manage prescription drug benefits on…
Deborah Dyett Desir, MD, Joins ACR Executive Committee as Secretary
To her new role as ACR Secretary, Dr. Desir brings extensive experience in both private practice and academic medicine, more than a decade of volunteer leadership experience in the ACR and a deep commitment to service.
ACR Advances Rheumatology Positions in American Medical Association Policies
At the American Medical Association House of Delegates Special Meeting held Nov. 13–17, 2020, the ACR’s delegation successfully led an effort to update AMA policies on home infusion and copay accumulators.
- « Previous Page
- 1
- …
- 4
- 5
- 6
- 7
- 8
- …
- 11
- Next Page »